Anatara Lifesciences Company Description

Anatara Lifesciences Ltd engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in Australia.

The company’s products include irritable bowel syndrome; and Detach for the treatment of diarrhea in piglets.

It also develops anti-obesity project, an oral complementary medication to assist weight reduction and control.

Anatara Lifesciences Ltd was incorporated in 2010 and is based in Adelaide, Australia.

Anatara Lifesciences Ltd

Country	Australia
Founded	2010
Industry	Biotechnology
Sector	Healthcare
CEO	David Brookes

Contact Details

Address: 81 Flinders Street Adelaide, SA 5000 Australia
Phone	61 4 3802 7172
Website	anataralifesciences.com

Stock Details

Ticker Symbol	ANR
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000ANR0
SIC Code	2836

Key Executives

Name	Position
Dr. David Lionel Brookes F.A.C.I.D., FACRRM, FAICD, MBBS	Executive Chairman and MD